I think it is obvious
For CXR to move up and have a chance to reach $30, $40 and more,
CEO Mark Thompson must RESIGN.
This stock will not move up otherwise.
Too many short sellers are after him and think he is a joke.
He is capable of bringing a startup company to $800M - $1B
company but not past that figure.
He must hand it off to someone else to continue the rest.
Obviously, his big mistake was buying a company bigger than they were
and thinking the drugs will sell as much as they had in the past for AMCO.
What he didn't see happening is price competition, buying off patent drugs,
Hillary tweeting and perhaps Europe tighting the prices.
If all remained the same, he may have pulled it off.
But things in the wrold change and he didn't have
that vision so time to pass the torch.